Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business....
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Fulgent Genetics (NASDAQ:FLGT) through any online brokerage.
Other companies in Fulgent Genetics’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Quest Diagnostics Inc (NYSE:DGX), Labcorp Holdings Inc (NYSE:LH) and Guardant Health Inc (NASDAQ:GH).
Fulgent Genetics has a consensus price target of $27.25.
The stock price for Fulgent Genetics (NASDAQ: FLGT) is $21.74 last updated October 9, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Fulgent Genetics.
Fulgent Genetics does not have any upcoming earnings scheduled.
There is no upcoming split for Fulgent Genetics.
Fulgent Genetics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.